Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 1;19(1):129-135.
doi: 10.2215/CJN.0000000000000244. Epub 2023 Jun 28.

Treatment Guidelines for Hyponatremia: Stay the Course

Collaborators, Affiliations
Review

Treatment Guidelines for Hyponatremia: Stay the Course

Richard H Sterns et al. Clin J Am Soc Nephrol. .

Abstract

International guidelines designed to minimize the risk of complications that can occur when correcting severe hyponatremia have been widely accepted for a decade. On the basis of the results of a recent large retrospective study of patients hospitalized with hyponatremia, it has been suggested that hyponatremia guidelines have gone too far in limiting the rate of rise of the serum sodium concentration; the need for therapeutic caution and frequent monitoring of the serum sodium concentration has been questioned. These assertions are reminiscent of a controversy that began many years ago. After reviewing the history of that controversy, the evidence supporting the guidelines, and the validity of data challenging them, we conclude that current safeguards should not be abandoned. To do so would be akin to discarding your umbrella because you remained dry in a rainstorm. The authors of this review, who represent 20 medical centers in nine countries, have all contributed significantly to the literature on the subject. We urge clinicians to continue to treat severe hyponatremia cautiously and to wait for better evidence before adopting less stringent therapeutic limits.

PubMed Disclaimer

Conflict of interest statement

D.M. Cohen reports advisory or leadership roles for VA Portland Health Care System (paid) and Portland VA Research Foundation (unpaid). M. Emmett reports payment for work as the editor of the Sodium/Hyponatremia-related chapters in UpToDate. F. Gankam-Kengne reports employment with EpiCURA. J.K. Hix reports ownership interest in Garden city company GCCO and Grayscale trust GBTC and honoraria from Lead Physician and Harris Interactive. E.J. Hoorn reports research funding from Aurinia; honoraria from UpToDate; roles of the Editorial Boards of American Journal of Physiology-Renal Physiology, JASN, and Journal of Nephrology; and roles as Board Member of ERA Working Group on Inherited Kidney Diseases and Board Member of Dutch Federation of Nephrology. K.S. Kamel reports royalties from Elsevier for publication of the fifth edition of the textbook Fluid and Electrolytes and Acid–Base Physiology: A Problem-Based Approach. N.E. Madias reports employment with Steward Medical Group and is a member of the St. Elizabeth's Medical Center, Boston, MA, Board of Trustees and the Hellenic College/Holy Cross School of Theology, Brookline, MA, Board of Trustees. A. Peri reports consultancy for Cantabria Labs Difa Cooper and research funding from Pfizer. H. Rondon-Berrios reports that he performed expert legal review in several medical malpractice lawsuits and that he is a member of the editorial board of CJASN. M.H. Rosner reports honoraria from American Society of Nephrology, advisory or leadership roles for American Society of Nephrology and data safety monitoring board for Retrophin and Reata, and role as Editor-at-Large for CJASN. M. Sherlock reports research funding from Pfizer, Shire, Ipsen, and Novartis. R.H. Sterns reports serving as an UpToDate Editor-in-Chief for Fluids and Electrolytes and has been remunerated for work as an expert witness in cases related to the treatment of hponatremia by attorneys for both plaintiff and defense. J.G. Verbalis reports consultancy for and honoraria from Otsuka. All remaining authors have nothing to disclose.

References

    1. Spasovski G Vanholder R Allolio B, . Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant. 2014;29(suppl 2):i1–i39. doi:10.1093/ndt/gfu040. - DOI - PubMed
    1. Verbalis JG Goldsmith SR Greenberg A, . Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 suppl 1):S1–S42. doi:10.1016/j.amjmed.2013.07.006. - DOI - PubMed
    1. Adrogue HJ, Tucker BM, Madias NE. Diagnosis and management of hyponatremia: a review. JAMA. 2022;328(3):280–291. doi:10.1001/jama.2022.11176. - DOI - PubMed
    1. Sterns RH. Treatment of severe hyponatremia. Clin J Am Soc Nephrol. 2018;13(4):641–649. doi:10.2215/CJN.10440917. - DOI - PMC - PubMed
    1. Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. J Am Soc Nephrol. 2017;28(5):1340–1349. doi:10.1681/ASN.2016101139. - DOI - PMC - PubMed

LinkOut - more resources